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In ischemic heart disease, cardiac MRI, besides being the gold standard for evaluation
of quantitative ventricular function, enables evaluation of myocardial wall thickness,
T2-weighted imaging for myocardial edema and infarct quantification and transmurality.
Delayed hyperenhancement sequences are highly predictive of scar formation, being
associated with myocyte necrosis. The extent and transmurality of delayed hyper-
enhancement has prognostic implications and is inversely proportional to the degree of
functional recovery after acute myocardial infarction. A greater transmural extent of
infarction (eg, hyperenhancement involving >50% of the wall thickness) can predict
regions that are less likely to improve in function after therapy. The ultimate focus of MRI
in ischemic heart disease is in diagnosis, quantification of myocardium at risk, salvageable
myocardium, perfusion defects and differentiation of viable myocardium from non viable
myocardium to enable prognostication.
Copyright ª 2013, Cardiological Society of India. All rights reserved.1. Clinical details 2. Cardiac MRI depictedA 74-year-old male, normotensive, non-diabetic, smoker, no
family history of ischemic heart disease with known coro-
nary artery disease sustained myocardial infarction 20 years
earlier. Coronary angiography revealed triple vessel disease
for which he underwent CABG 18 years previously. The pa-
tient presented with dyspnea on exertion, relieved on rest.
On admission pulse 60/min, BP 120/80 mm Hg. 2D echo
Doppler Color revealed akinetic anterior septum, IVS, apex,
anterior wall, LVEF 30%, normal LV dimensions with dilated
LA. Trace MR. Cardiac MRI was requested for viability
assessment.m, mona.bhatia@fortishe
2013, Cardiological SocietLV Functional analysis: LVEDV: 146 ml, LVESV: 104 ml, LVEF:
29%, Stroke volume: 42 ml and Cardiac output: 2.2 l/min.
There was myocardial involvement in the basal anterior,
anteroseptal and inferoseptal; mid cavity anterolateral, ante-
rior, antero septal, inferoseptal, and inferior; apical septal,
anterior, inferior and lateral wall and apex of the LV with
segments of wall thinning (wall thickness <5 mm), severe
hypokinesia to akinesia in part and apical dyskinesia with
perfusion defect (Fig. 1) and post contrast hyperenhancement
extending from the subendocardial to the epicardial surface,
varying in transmurality from <25% to >75% wall thicknessalthcare.com.
y of India. All rights reserved.
Fig. 1 e Defect on first pass perfusion at the site of
myocardial thinning.
Fig. 2 e Delayed post contrast enhanced imaging on short
axis views demonstrating subendocardial to near
transmural scar formation in the anterior, antero septal
and inferoseptal segments at mid cavity level.
Fig. 3 e Delayed post contrast enhanced imaging in the 4
chamber view demonstrating basal, mid cavity and apical
septal subendocardial scar formation with near transmural
involvement in part.
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myocardium (Figs. 2 and 3). The extent of myocardial infarc-
tion was 19% of the LV myocardial volume. Ballooning of the
LV apex was seen. Trace MR was evident. There was no MRI
evidence of contained thrombus ormass. The interventricular
septum was intact.3. Conclusion
Myocardial viability is critical in the evaluation and manage-
ment of patients with ischemic heart disease. Cardiac MRI
with its improved spatial and temporal resolution now
permits accurate and non invasive evaluation of cardiac
morphology, function, regional and global myocardial
wall motion abnormalities, myocardial edema, perfusion,
ischemia and scar assessment.Conflicts of interest
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